GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (NYSE:TFX) » Definitions » Cyclically Adjusted PS Ratio

Teleflex (Teleflex) Cyclically Adjusted PS Ratio : 3.49 (As of Apr. 27, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Teleflex Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Teleflex's current share price is $206.71. Teleflex's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $59.25. Teleflex's Cyclically Adjusted PS Ratio for today is 3.49.

The historical rank and industry rank for Teleflex's Cyclically Adjusted PS Ratio or its related term are showing as below:

TFX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.52   Med: 4.43   Max: 9.24
Current: 3.49

During the past years, Teleflex's highest Cyclically Adjusted PS Ratio was 9.24. The lowest was 1.52. And the median was 4.43.

TFX's Cyclically Adjusted PS Ratio is ranked worse than
63.01% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs TFX: 3.49

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Teleflex's adjusted revenue per share data for the three months ended in Dec. 2023 was $16.360. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $59.25 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Teleflex Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Teleflex's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Cyclically Adjusted PS Ratio Chart

Teleflex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.34 8.77 6.35 4.45 4.21

Teleflex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.45 4.42 4.15 3.32 4.21

Competitive Comparison of Teleflex's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Teleflex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teleflex's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teleflex's Cyclically Adjusted PS Ratio falls into.



Teleflex Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Teleflex's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=206.71/59.25
=3.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Teleflex's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=16.36/129.4194*129.4194
=16.360

Current CPI (Dec. 2023) = 129.4194.

Teleflex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 9.586 99.695 12.444
201406 10.090 100.560 12.986
201409 9.805 100.428 12.636
201412 10.104 99.070 13.199
201503 9.080 99.621 11.796
201506 9.402 100.684 12.085
201509 9.143 100.392 11.787
201512 10.026 99.792 13.003
201603 8.710 100.470 11.220
201606 10.023 101.688 12.756
201609 9.604 101.861 12.202
201612 10.909 101.863 13.860
201703 10.466 102.862 13.168
201706 11.291 103.349 14.139
201709 11.478 104.136 14.265
201712 12.760 104.011 15.877
201803 12.576 105.290 15.458
201806 13.380 106.317 16.287
201809 13.023 106.507 15.825
201812 13.695 105.998 16.721
201903 13.071 107.251 15.773
201906 13.873 108.070 16.614
201909 13.743 108.329 16.419
201912 14.425 108.420 17.219
202003 13.352 108.902 15.868
202006 12.003 108.767 14.282
202009 13.274 109.815 15.644
202012 15.022 109.897 17.691
202103 13.372 111.754 15.486
202106 15.042 114.631 16.982
202109 14.757 115.734 16.502
202112 16.069 117.630 17.680
202203 13.538 121.301 14.444
202206 14.880 125.017 15.404
202209 14.531 125.227 15.018
202212 16.051 125.222 16.589
202303 15.035 127.348 15.280
202306 15.704 128.729 15.788
202309 15.780 129.860 15.727
202312 16.360 129.419 16.360

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Teleflex  (NYSE:TFX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Teleflex Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Teleflex's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Teleflex (Teleflex) Business Description

Traded in Other Exchanges
Address
550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.
Executives
Liam Kelly officer: EVP & President, International IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000
Thomas E Powell officer: Senior Vice President & CFO C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717
Stuart A Randle director 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Jaewon Ryu director 950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203
Neena M Patil director JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304
Andrew A Krakauer director CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Cameron P Hicks officer: Vice President, Global HR 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Klasko Stephen K. M.d. director 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Jay White officer: VP & Pres, Global Commercial 3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560
Daniel V. Logue officer: VP, Gen Counsel & Secretary 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
John Deren officer: VP & Chief Accounting Officer 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
James J Leyden officer: VP, General Counsel, Secretary C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014
James Winters officer: Vice President, Mfg and Supply 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Mario Wijker officer: Vice President, QARA 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Benson Smith director C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976